“We congratulate our board member, Andy von Eschenbach, who as former head of the FDA and director of the National Cancer Institute, had the vision, relationships, and tenacity to help define and drive the 21st Century Cures Act to fruition,” says Foundation Chairman Neal F. Kassell, MD
"21st Century Cures is the most transformational legislation impacting biomedical research since the National Cancer Act of 1971. It provides essential resources for critical programs like the Cancer Moonshot, precision medicine, and brain research. More importantly, its many policy provisions will enhance and accelerate the discovery, development and delivery of innovative lifesaving interventions," says Dr. von Eschenbach.
This new law will boost funding for medical research by providing nearly $5 billion for NIH and easing the development and approval of experimental treatments. The Foundation applauds this initiative, which aligns with our mission to bring new technologies to patients in the shortest time possible. We are optimistic that the streamlined and updated medical research and regulatory process will help to accelerate progress for focused ultrasound.
READ HOW THE LAW WILL AFFECT MEDICAL DEVICES >